Federico Vizcaino, MD
Psychiatry · Portsmouth, VANPI 1295729309
Payments from drug & device makers
Across 233 payments — averaging $16.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$750
- Otsuka America Pharmaceutical, Inc.$308
- E.r. Squibb & Sons, L.L.C.$271
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$249
- Alkermes, Inc.$206
- plus $974 from 17 others
What the payments were for
- Food & beverage$3,881100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 83 | $1,122 |
| Johnson & Johnson | 38 | $750 |
| Otsuka America Pharmaceutical, Inc. | 16 | $308 |
| E.r. Squibb & Sons, L.L.C. | 15 | $271 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $249 |
| Alkermes, Inc. | 12 | $206 |
| Vanda Pharmaceuticals Inc. | 9 | $176 |
| Teva Pharmaceuticals USA, Inc. | 9 | $142 |
| Lundbeck LLC | 7 | $123 |
| Neurocrine Biosciences, Inc. | 6 | $117 |
| Corium, LLC | 3 | $61 |
| Almatica Pharma LLC | 3 | $45 |
| Tris Pharma Inc | 2 | $45 |
| Sunovion Pharmaceuticals Inc. | 5 | $45 |
| Avanir Pharmaceuticals, Inc. | 3 | $42 |
| Ironshore Pharmaceuticals Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $31 |
| Jazz Pharmaceuticals Inc. | 2 | $30 |
| Harmony Biosciences LLC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Bausch Health US, LLC | 1 | $20 |
| Adlon Therapeutics L.p. | 1 | $12 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
How this compares
$3,881 in reported general payments places this provider in the 85th percentile of 884 psychiatry providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 51 | $3,433 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 19 | $2,621 |
| Duloxetine Hcl | 73 | $1,919 |
| Bupropion Hcl SrBupropion Hcl | 14 | $988 |
| Bupropion XlBupropion Hcl | 13 | $927 |
| Trazodone Hcl | 135 | $803 |
| Alprazolam | 140 | $625 |
| Olanzapine | 11 | $567 |
| Lorazepam | 137 | $566 |
| Fluoxetine Hcl | 42 | $540 |
| Ziprasidone Hcl | 12 | $473 |
| Quetiapine Fumarate | 40 | $426 |
| Clonazepam | 68 | $376 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 17 | $345 |
| Carbamazepine | 11 | $289 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Portsmouth
- Niku SinghFalls Church$2.5M
- David ScheidererRoanoke$2.4M
- Kent McDanielGlen Allen$2.1M
- Jasdeep MiglaniManassas$958K
- Frederick MoellerRichmond$678K
- David SpiegelNorfolk$565K
- Christopher van EyckStafford$392K
- Anita ClaytonCharlottesville$356K
- Anita KablingerRoanoke$333K
- William YetterVirginia Beach$312K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.